Japan To Subsidize Four Drug Makers For More Cell-Based Flu Vaccines
This article was originally published in PharmAsia News
Executive Summary
Japan's health ministry announced a new incentive program for four local drug makers and suppliers to increase production of flu vaccines based on cell-based technology